Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
6.26
-0.23 (-3.54%)
At close: Jul 18, 2025, 4:00 PM
6.22
-0.04 (-0.64%)
After-hours: Jul 18, 2025, 4:10 PM EDT
Bioventus Stock Forecast
Stock Price Forecast
The 5 analysts that cover Bioventus stock have a consensus rating of "Strong Buy" and an average price target of $14.4, which forecasts a 130.03% increase in the stock price over the next year. The lowest target is $12 and the highest is $17.
Price Target: $14.4 (+130.03%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Bioventus stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $12 | Buy | Initiates | $12 | +91.69% | Jul 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +139.62% | Mar 17, 2025 |
| JP Morgan | JP Morgan | Sell → Hold Upgrades $12 → $13 | Sell → Hold | Upgrades | $12 → $13 | +107.67% | Dec 17, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $15 | Strong Buy | Maintains | $12 → $15 | +139.62% | Nov 6, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $12 → $17 | Strong Buy | Maintains | $12 → $17 | +171.57% | Sep 27, 2024 |
Financial Forecast
Revenue This Year
570.85M
from 573.28M
Decreased by -0.42%
Revenue Next Year
605.73M
from 570.85M
Increased by 6.11%
EPS This Year
0.71
from -0.52
EPS Next Year
0.90
from 0.71
Increased by 25.47%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 594.3M | 632.9M | 657.3M |
| Avg | 570.9M | 605.7M | 632.3M |
| Low | 553.4M | 584.1M | 613.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.7% | 10.9% | 8.5% |
| Avg | -0.4% | 6.1% | 4.4% |
| Low | -3.5% | 2.3% | 1.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.84 | 1.05 | 0.84 |
| Avg | 0.71 | 0.90 | 0.81 |
| Low | 0.65 | 0.72 | 0.78 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 47.1% | -6.2% |
| Avg | - | 25.5% | -9.8% |
| Low | - | 0.2% | -12.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.